2021 AATS专家共识:冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭

2021-09-01 美国胸外科协会 Journal of Thoracic and Cardiovascular Surgery c

21年9月,美国胸外科协会(AATS)发布了冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭共识。本文的主要目的是为冠状动脉旁路移植术治疗治疗缺血性心肌病(ICM)和心力衰竭患者提供共识指导。

中文标题:

2021 AATS专家共识:冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭

英文标题:

2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure

发布机构:

美国胸外科协会

发布日期:

2021-09-01

简要介绍:

21年9月,美国胸外科协会(AATS)发布了冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭共识。本文的主要目的是为冠状动脉旁路移植术治疗治疗缺血性心肌病(ICM)和心力衰竭患者提供共识指导。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 AATS专家共识:冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6c6331c002186af3, title=2021 AATS专家共识:冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭, enTitle=2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure, guiderFrom=Journal of Thoracic and Cardiovascular Surgery c, authorId=0, author=, summary=21年9月,美国胸外科协会(AATS)发布了冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭共识。本文的主要目的是为冠状动脉旁路移植术治疗治疗缺血性心肌病(ICM)和心力衰竭患者提供共识指导。, cover=https://img.medsci.cn/2021914/1631625039441_5579292.jpg, journalId=0, articlesId=null, associationId=58, associationName=美国胸外科协会, associationIntro=AATS由胸外科领域的先驱者成立于1917年,目前是一个拥有超过1200名会员的国际性组织,会员由来自35个不同国家的顶级心胸外科医生组成。申请入会的外科医生必须在心胸外科领域取得了一定荣誉或对心胸疾病现有知识作出了一定贡献。协会通过年会、研究基金和奖励、教育座谈会和课程和旗下官方期刊the Journal of Thoracic and Cardiovascular Surgery (JTCVS)来促进对本学科的科学、教育和研究的发展。, copyright=0, guiderPublishedTime=Wed Sep 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">21年9月,美国胸外科协会(AATS)发布了冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭共识。本文的主要目的是为冠状动脉旁路移植术治疗治疗缺血性心肌病(ICM)和心力衰竭患者提供共识指导。</span></p>, tagList=[TagDto(tagId=2769, tagName=冠状动脉旁路移植术)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2769, guiderKeyword=冠状动脉旁路移植术, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4295, appHits=92, showAppHits=0, pcHits=463, showPcHits=4202, likes=1, shares=14, comments=5, approvalStatus=1, publishedTime=Wed Sep 15 20:44:58 CST 2021, publishedTimeString=2021-09-01, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Sep 14 21:11:55 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 22:33:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AATS专家共识:冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭.pdf)])
2021 AATS专家共识:冠状动脉旁路移植术治疗缺血性心肌病和心力衰竭.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1208431, encodeId=533912084311b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628096168, createdName=Alliswell999, createdTime=Sun Apr 03 21:36:43 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076731, encodeId=ea9110e6731d6, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/3490cc7ee4a2417bae03314d2ca28bfe/87a1295534564643a59f57691bc7304f.jpg, createdBy=8ebd2201249, createdName=鲁咏, createdTime=Sat Dec 04 08:35:34 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064452, encodeId=76731064452ca, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Wed Oct 27 19:53:38 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056328, encodeId=05611056328a3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Thu Sep 30 00:28:08 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2022-04-03 Alliswell999

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1208431, encodeId=533912084311b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628096168, createdName=Alliswell999, createdTime=Sun Apr 03 21:36:43 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076731, encodeId=ea9110e6731d6, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/3490cc7ee4a2417bae03314d2ca28bfe/87a1295534564643a59f57691bc7304f.jpg, createdBy=8ebd2201249, createdName=鲁咏, createdTime=Sat Dec 04 08:35:34 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064452, encodeId=76731064452ca, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Wed Oct 27 19:53:38 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056328, encodeId=05611056328a3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Thu Sep 30 00:28:08 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-12-04 鲁咏

    实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1208431, encodeId=533912084311b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628096168, createdName=Alliswell999, createdTime=Sun Apr 03 21:36:43 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076731, encodeId=ea9110e6731d6, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/3490cc7ee4a2417bae03314d2ca28bfe/87a1295534564643a59f57691bc7304f.jpg, createdBy=8ebd2201249, createdName=鲁咏, createdTime=Sat Dec 04 08:35:34 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064452, encodeId=76731064452ca, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Wed Oct 27 19:53:38 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056328, encodeId=05611056328a3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Thu Sep 30 00:28:08 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-10-27 1e1366a1m07(暂无匿称)

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1208431, encodeId=533912084311b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628096168, createdName=Alliswell999, createdTime=Sun Apr 03 21:36:43 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076731, encodeId=ea9110e6731d6, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/3490cc7ee4a2417bae03314d2ca28bfe/87a1295534564643a59f57691bc7304f.jpg, createdBy=8ebd2201249, createdName=鲁咏, createdTime=Sat Dec 04 08:35:34 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064452, encodeId=76731064452ca, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Wed Oct 27 19:53:38 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056328, encodeId=05611056328a3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Thu Sep 30 00:28:08 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-09-30 Doctoryangbai

    学习了

    0